Skip to main content
SpringerLink
Log in

Dual versus triple therapy for patients with atrial fibrillation and acute coronary syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials

  • Letter to the Editor
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Cho J, Angiolillo D (2015) Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma. J Thromb Thrombolysis 39:203–208

    Article  PubMed  Google Scholar 

  2. January C, Wann L, Calkins H et al (2019) 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart R. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2019.01.011

    Article  PubMed  Google Scholar 

  3. So C, Eckman M (2017) Combined aspirin and anticoagulant therapy in patients with atrial fibrillation. J Thromb Thrombolysis 43:7–17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chi G, Yee M, Kalayci A et al (2018) Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention. J Thromb Thrombolysis 46:346–350

    Article  CAS  PubMed  Google Scholar 

  5. Brok J, Thorlund K, Wetterslev J, Gluud C (2009) Apparently conclusive meta-analyses may be inconclusive–trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol 38:287–298. https://doi.org/10.1093/ije/dyn188

    Article  PubMed  Google Scholar 

  6. Dewilde WJM, Oirbans T, Verheugt FWA et al (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381:1107–1115

    Article  CAS  PubMed  Google Scholar 

  7. Gibson CM, Mehran R, Bode C et al (2016) Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 375:2423–2434

    Article  CAS  PubMed  Google Scholar 

  8. Cannon CP, Bhatt DL, Oldgren J et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377:1513–1524

    Article  CAS  PubMed  Google Scholar 

  9. Lopes R, Heizer G, Aronson R et al (2019) Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med 380:1509–1524. https://doi.org/10.1056/NEJMoa1817083

    Article  CAS  PubMed  Google Scholar 

  10. Fiedler KA, Maeng M, Mehilli J et al (2015) Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial. J Am Coll Cardiol 65:1619–1629

    Article  PubMed  Google Scholar 

  11. Lip G, Collet J, Haude M et al (2019) 2018 joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the Europ. Europace 21:192–193

    Article  PubMed  Google Scholar 

  12. Angiolillo D, Goodman S, Bhatt D et al (2018) Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention. a North American perspective–2018 update. Circulation 138:527–536

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Hurley Medical Center, Michigan State University, Two Hurley Plaza, Suite 212, Flint, MI, 48503, USA

    Babikir Kheiri, Mahmoud Barbarawi, Yazan Zayed, Sahar Ahmed & Ghassan Bachuwa

  2. Division of Cardiology, West Virginia University School of Medicine, Morgantown, WV, USA

    Mohammed Osman

  3. Division of Cardiology, Saint Vincent Hospital, Worcester, MA, USA

    Ahmed Bakhit

  4. Midwest Cardiovascular Research Foundation, Davenport, IA, USA

    Qais Radaideh

  5. Division of Hematology & Oncology, St. John Hospital, Grosse Pointe Woods, MI, 48236, USA

    Ahmed Abdalla

  6. Division of Cardiology, Hurley Medical Center, Michigan State University, Flint, MI, USA

    Mustafa Hassan

Authors
  1. Babikir Kheiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammed Osman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmed Bakhit
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qais Radaideh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ahmed Abdalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mahmoud Barbarawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yazan Zayed
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sahar Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ghassan Bachuwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Mustafa Hassan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Babikir Kheiri.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kheiri, B., Osman, M., Bakhit, A. et al. Dual versus triple therapy for patients with atrial fibrillation and acute coronary syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials. J Thromb Thrombolysis 48, 511–513 (2019). https://doi.org/10.1007/s11239-019-01874-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-019-01874-1

Search

Navigation